Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov:38:100817.
doi: 10.1016/j.nmni.2020.100817. Epub 2020 Nov 19.

SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt

Affiliations

SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt

M A M Iesa et al. New Microbes New Infect. 2020 Nov.

Abstract

Coronavirus disease 2019 (COVID-19) has caused significant morbidity and mortality and new cases are on the rise globally, yet malaria-endemic areas report statistically significant lower incidences. We identified potential shared targets for an immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by immune determinants' shared identities with P. falciparum using the Immune Epitope Database and Analysis Resource Immune 9.0 browser tool. Probable cross-reactivity is suggested through HLA-A∗02:01 and subsequent CD8+ T-cell activation. The apparent immunodominant epitope conservation between SARS-CoV-2 (N and open reading frame (ORF) 1ab) and P. falciparum thrombospondin-related anonymous protein (TRAP) may underlie the low COVID-19 incidence in the malaria-endemic zone by providing immunity against virus infection to those previously infected with Plasmodium. Additionally, we hypothesize that the shared epitopes which lie within antigens that aid in the establishment of the P. falciparum erythrocyte invasion may be an alternative route for SARS-CoV-2 via the erythrocyte CD147 receptor, although this remains to be proven.

Keywords: CD147 receptor; Plasmodium falciparum; SARS-CoV-2; epitope; homology.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Coronavirus disease 2019 (COVID-19) vs. malaria. (A) Comparison between COVID-19 and malaria case numbers within different high burden–high incidence (HBHI) malaria regions. (B) Comparison between Plasmodium falciparum (Pf), P. vivax (Pv) and COVID-19 case percentages within HBHI malaria regions.
Fig. 2
Fig. 2
T-cell–immunodominant regions based on Plasmodium falciparum–targeted proteins. (A) Apical membrane protein 1 (AMP-1). (B) Merozoite surface protein 1 (MSP-1). (C) Circumsporozoite protein (CSP). (D) Thrombospondin-related anonymous protein (TRAP). Specific epitope mapping response frequency (RF) score for each amino acid position was calculated and plotted over severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) consensus sequences. Cross-immune reactivity between P. falciparum and SARS-CoV-2 was identified.

References

    1. Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. - PMC - PubMed
    1. Fauci A.S., Lane H.C., Redfield R.R. Covid-19—navigating the uncharted. N Engl J Med. 2020;382:1268–1269. - PMC - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. World Health Organization (WHO) 4 December 2019. World malaria report 2019.https://www.who.int/publications/i/item/9789241565721 Available at:
    1. World Health Organization (WHO) Malaria country profile 2018. https://www.who.int/malaria/publications/world-malaria-report-2018/en/ Available at: